The company’s first and largest consumer advertising campaign
Featured on major TV channels and mainstream print publications
SAN CLEMENTE, Calif., October 12, 2021 (GLOBE NEWSWIRE) – ReShape Lifesciences Inc. (NASDAQ: RSLS), the leading physician-led weight loss and metabolic health solutions company, has announced the launch of a product consumer multiplatform advertising campaign using national television, print media, social media and public relations to market their next-generation Lap-BandÂ® program with available tracking supported by reshapecare â¢, their virtual health coaching platform reimbursable to educate consumers and increase patient demand.
Research shows that more than 2.1 billion people, nearly 30 percent of the world’s population, are overweight or obese, with projections suggesting that nearly half of the world’s adult population will be overweight or obese by 20301 In addition, the American Psychological Association recently announced results of a February 2021 poll by The Harris Poll revealing that a majority of adults (61%) have reported unwanted weight changes since the start of the COVID-19 pandemic, with more than 2 in 5 (42 %) claiming to have gained more weight than them. planned 2. Of this group, adults reported gaining an average of 29 pounds. ReShape Lifesciences â¢ designed this national campaign to build awareness of the Lap-Band brand and a call to action for those looking for a personalized and effective weight loss program that puts control in the hands of the patient without radical change in their daily lifestyle.
To view the elements of the direct-to-consumer marketing campaign, please access through this link: https://sincbox.gosimian.com/sp/a/FnTB0eGItGYPpjpw1b3VNQ/.
Proven by clinicians around the world, Lap-Band is the safest, minimally invasive bariatric surgery procedure approved by the FDA, covered by most insurance plans, performed on an outpatient basis and available in the market today. With over two decades of data, the Adjustable and Reversible Lap-Band has demonstrated lower complication and mortality rates than other weight loss surgical procedures.
âIn an effort to address this growing health problem associated with weight gain and to help more people improve their quality of life, we have invested significant time and resources to study current test marketing programs in correlation with the historical impact of direct marketing to patients on Lap. – Band patient demand. Based on these metrics, we are confident that targeted national advertising on this major scale will highlight the exclusive benefits of Lap-Band, resulting in higher procedural volumes and corresponding revenues, âcommented Bart Bandy, President and CEO of ReShape Lifesciences.
National TV spots will appear in media such as HSTG, CCM, FOX, well done, and more, with print ads running in Magazine, , ,, and other nationally selected publications. This coordinated media aims to reach out to people struggling to maintain a healthy weight and educate them about the benefits and affordability of the Lap-Band procedure over other treatment options. Another goal of the campaign is to help people understand that the Lap-Band offers unique benefits for a variety of patients, including those with lower BMIs and women at risk of becoming pregnant.
âThis is an exciting time for the company as we are able to leverage specific medical device and brand benefits nationwide unlike any other weight loss or weight loss program. bariatric surgery. As we build on this impactful, comprehensive and brand-specific advertising campaign, it can also serve as a co-marketing resource for firms to promote the Lap-Band and directly advance their consultation and the growth of their firms. procedures, âsaid Diane Utzman-O’Neill, vice president of consumer marketing at ReShape Lifesciences.
ABOUT RESHAPE LIFESCIENCES INC.
ReShape Lifesciences â¢ is America’s premier weight loss and metabolic health solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-BandÂ® program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest â¢ System is an investigational (outside of the United States) minimally invasive laparoscopically implanted medical device that wraps around the stomach, mimicking the gastric volume reduction effect of conventional blood loss surgery. weight. It helps enable rapid weight loss in obese and morbidly obese patients without permanently altering the patient’s anatomy. reshapecare â¢ is a virtual weight management program that supports lifestyle changes for all weight loss patients, led by board-certified health coaches to help them maintain their weight over time. time. The recently launched ReShape Marketplace â¢ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals.
Forward-looking statement on the Safe Harbor:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by the use of words such as âexpectâ, âplanâ, âanticipateâ , “Could”, “could”, “intention”, “will”, “continue”, “in the future”, other words with similar meaning and the use of future dates. Forward-looking statements contained in this press release include statements about our confidence that targeted national advertising on this major scale will highlight the exclusive benefits of Lap-Band, resulting in higher procedural volumes and corresponding revenue. These forward-looking statements are based on the current expectations of our management and involve known and unknown risks and uncertainties which may cause our actual results, performances or achievements to be materially different from the future results, performances or achievements expressed or implied. by forward-looking statements. These risks and uncertainties are described in more detail in the documents filed by the Company with the Securities and Exchange Commission, in particular the factors identified as ârisk factorsâ in our annual report on Form 10-K filed on March 11, 2021. We are providing this information as of the date of this press release and assume no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise, unless the law requires it.
ReShape Lifesciences investor contact: Thomas Stankovich Chief Financial Officer 949-276-6042 [email protected]
Investor Contact: Daniel Kontoh-Boateng Assistant Vice President The Ruth Group 646-536-7019 [email protected]
McKinsey Global Institute, Beating Obesity: An Initial Economic Analysis. November 2014.
https://www.mckinsey.com/~/media/mckinsey/business%20functions/economic%20studies%20temp/our%20insights/how%20the%20world%20could%20better%20fight%20obesity/mgiâsurmonterâl ‘ obesityâ complete â report.ashx
American Psychological Association, One Year Later: Unhealthy Weight Gains, Increased Alcohol Use Reported by Americans Facing Pandemic Stress. March 2021.